KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Gains from Investment Securities (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed Gains from Investment Securities for 11 consecutive years, with -$2.5 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities fell 4759.62% to -$2.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$196000.0 through Dec 2025, down 107.65% year-over-year, with the annual reading at $700000.0 for FY2025, 460.0% up from the prior year.
  • Gains from Investment Securities hit -$2.5 million in Q4 2025 for Fulgent Genetics, down from $18000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $1.7 million in Q1 2024 to a low of -$2.5 million in Q4 2025.
  • Historically, Gains from Investment Securities has averaged -$13050.0 across 5 years, with a median of $18000.0 in 2024.
  • Biggest five-year swings in Gains from Investment Securities: skyrocketed 1121.43% in 2021 and later crashed 9775.0% in 2022.
  • Year by year, Gains from Investment Securities stood at $12000.0 in 2021, then plummeted by 9775.0% to -$1.2 million in 2022, then surged by 160.38% to $701000.0 in 2023, then crashed by 107.42% to -$52000.0 in 2024, then tumbled by 4759.62% to -$2.5 million in 2025.
  • Business Quant data shows Gains from Investment Securities for FLGT at -$2.5 million in Q4 2025, $18000.0 in Q3 2025, and $18000.0 in Q2 2025.